Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(0.83)
# 3,929
Out of 5,182 analysts
181
Total ratings
21.76%
Success rate
-10.48%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.37 | +556.93% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $200 | $1.16 | +17,216.02% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $6.47 | +193.66% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.14 | +250.88% | 7 | Apr 8, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $200 | $2.51 | +7,868.13% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $3.09 | +514.89% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $17.59 | +19.39% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $0.86 | +1,653.77% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $560 | $2.30 | +24,247.83% | 9 | Mar 10, 2025 | |
| ENVB Enveric Biosciences | Reiterates: Buy | $120 | $3.99 | +2,907.52% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $5.10 | +684.31% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $3.39 | +2,554.87% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $8.04 | +136.32% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.69 | +333.60% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.79 | +659.49% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.70 | +14,185.71% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $2.93 | +6,725.94% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.63 | +660.46% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $4.95 | +318,081.82% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $7.61 | +6,470.30% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $31.69 | +657.46% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.88 | +8,989.88% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $12.78 | +62,497.81% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.58 | +343.04% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $1.15 | +2,508.70% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $4.38 | +813.24% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $2.28 | +689.47% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.27 | +120.26% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $63.35 | -62.12% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $0.57 | +598,744.34% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.09 | +1,751,052.07% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.37
Upside: +556.93%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $200
Current: $1.16
Upside: +17,216.02%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $6.47
Upside: +193.66%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.14
Upside: +250.88%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $200
Current: $2.51
Upside: +7,868.13%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $3.09
Upside: +514.89%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $17.59
Upside: +19.39%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.86
Upside: +1,653.77%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $560
Current: $2.30
Upside: +24,247.83%
Enveric Biosciences
Mar 6, 2025
Reiterates: Buy
Price Target: $120
Current: $3.99
Upside: +2,907.52%
Mar 5, 2025
Reiterates: Buy
Price Target: $40
Current: $5.10
Upside: +684.31%
Mar 4, 2025
Reiterates: Buy
Price Target: $90
Current: $3.39
Upside: +2,554.87%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $8.04
Upside: +136.32%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $3.69
Upside: +333.60%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.79
Upside: +659.49%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $0.70
Upside: +14,185.71%
Nov 12, 2024
Reiterates: Buy
Price Target: $200
Current: $2.93
Upside: +6,725.94%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.63
Upside: +660.46%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $4.95
Upside: +318,081.82%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $7.61
Upside: +6,470.30%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $31.69
Upside: +657.46%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.88
Upside: +8,989.88%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $12.78
Upside: +62,497.81%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.58
Upside: +343.04%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $1.15
Upside: +2,508.70%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $4.38
Upside: +813.24%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $2.28
Upside: +689.47%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $2.27
Upside: +120.26%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $63.35
Upside: -62.12%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $0.57
Upside: +598,744.34%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.09
Upside: +1,751,052.07%